SCHEMBL4657925

SCHEMBL4657925

CCC(CC#N)Cc1cccc([N+](=O)[O-])c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.48
PYCR1 P32322 1/20 0.47
CYP2C19 P33261 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 2/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
MAOB P27338 2/20 0.41
ACHE P22303 1/20 0.41
CYP3A4 P08684 1/20 0.40
RECQL P46063 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
HPGD P15428 1/20 0.39
MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4657130 0.83 TSHR (0.50) TSHRPYCR1CYP2C19CYP1A2CYP2D6
SCHEMBL4657794 0.81 TSHR (0.54) TSHRPYCR1CYP2C19CYP1A2CYP2D6
SCHEMBL25955583 0.80 TSHR (0.49) TSHRPYCR1CYP2C19CYP1A2CYP2D6
SCHEMBL4657090 0.78 FFAR1 (0.52) TSHRCYP2C19CYP1A2CYP2D6CYP2C9
SCHEMBL4657690 0.77 TSHR (0.47) TSHRCYP2C19CYP1A2CYP2D6CYP2C9
SCHEMBL18400704 0.77 TSHR (0.56) TSHRPYCR1CYP2C19CYP1A2CYP2D6
SCHEMBL9918209 0.75 HTT (0.45) TSHRCYP1A2ALDH1A1KDM4ELMNA
SCHEMBL347820 0.75 TSHR (0.61) TSHRPYCR1CYP2C19CYP1A2CYP2D6
SCHEMBL4600404 0.75 TSHR (0.61) TSHRPYCR1CYP2C19CYP1A2CYP2D6
SCHEMBL17791450 0.74 TSHR (0.43) TSHRPYCR1CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1295864-B1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES MITSUI CHEMICALS POLYURETHANES (JP) 2008-12-03 EP disclosed
US-6737548-B2 REACTING AN ORTHO-ALKYLNITROBENZENE WITH VINYL COMPOUND IN PRESENCE OF A BASE TO PRODUCE AN INTERMEDIATE, CYCLIZING THE INTERMEDIATE TO FORM 5-NITRO-1-TETRALONE COMPOUND, THEN REACTING WITH AMINE TO PRODUCE DIAMINONAPHTHALENE COMPOUNDS MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes MITSUI CHEMICALS POLYURETHANES, INC. (JP) 2003-09-18 US disclosed
EP-1295864-A1 PROCESS FOR PREPARATION OF 1,5-DIAMINONAPHTHALENES Mitsui Chemicals, Inc. (JP) 2003-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176722-A1 Process for preparation of 1,5-diaminonaphthalenes NOX5, NOX1, DPYD TSHR 4208/4885PYCR1 432/4885CYP2C19 647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.